Botanix Pharmaceuticals BXPHF Stock
Botanix Pharmaceuticals Price Chart
Botanix Pharmaceuticals BXPHF Financial and Trading Overview
| Botanix Pharmaceuticals stock price | 0.25 USD |
| Previous Close | 0.06 USD |
| Open | 0.06 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.06 - 0.06 USD |
| 52 Week Range | 0.02 - 0.19 USD |
| Volume | 7.5K USD |
| Avg. Volume | 1.97K USD |
| Market Cap | 88.76M USD |
| Beta (5Y Monthly) | 1.948659 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BXPHF Valuation Measures
| Enterprise Value | 62.57M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.028783 |
| Price/Book (mrq) | 4.285714 |
| Enterprise Value/Revenue | 9.184 |
| Enterprise Value/EBITDA | -5.56 |
Trading Information
Botanix Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.948659 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.09 USD |
| 200-Day Moving Average | 0.05 USD |
BXPHF Share Statistics
| Avg. Volume (3 month) | 1.97K USD |
| Avg. Daily Volume (10-Days) | 2.3K USD |
| Shares Outstanding | 1.31B |
| Float | 966.32M |
| Short Ratio | N/A |
| % Held by Insiders | 20.83% |
| % Held by Institutions | 9.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -165.27% |
| Operating Margin (ttm) | -165.45% |
| Gross Margin | -69.51% |
| EBITDA Margin | -165.16% |
Management Effectiveness
| Return on Assets (ttm) | -36.99% |
| Return on Equity (ttm) | -72.23% |
Income Statement
| Revenue (ttm) | 6.81M USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | 8428.10% |
| Gross Profit (ttm) | -7537672 USD |
| EBITDA | -11251809 USD |
| Net Income Avi to Common (ttm) | -11258940 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.72M USD |
| Total Cash Per Share (mrq) | 0.007 USD |
| Total Debt (mrq) | 32.42K USD |
| Total Debt/Equity (mrq) | 0.19 USD |
| Current Ratio (mrq) | 3.082 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12285044 USD |
| Levered Free Cash Flow (ttm) | -16271205 USD |
Profile of Botanix Pharmaceuticals
| Country | United States |
| State | WA |
| City | Leederville |
| Address | D2, 661 Newcastle Street |
| ZIP | 6007 |
| Phone | 61 8 6555 2945 |
| Website | https://www.botanixpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 11 |
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.
Q&A For Botanix Pharmaceuticals Stock
What is a current BXPHF stock price?
Botanix Pharmaceuticals BXPHF stock price today per share is 0.25 USD.
How to purchase Botanix Pharmaceuticals stock?
You can buy BXPHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Botanix Pharmaceuticals?
The stock symbol or ticker of Botanix Pharmaceuticals is BXPHF.
Which industry does the Botanix Pharmaceuticals company belong to?
The Botanix Pharmaceuticals industry is Biotechnology.
How many shares does Botanix Pharmaceuticals have in circulation?
The max supply of Botanix Pharmaceuticals shares is 1.85B.
What is Botanix Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Botanix Pharmaceuticals PE Ratio is now.
What was Botanix Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Botanix Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Botanix Pharmaceuticals company belong to?
The Botanix Pharmaceuticals sector is Healthcare.